Publications by authors named "Maria Ruiz de Arcos"
Background: Alemtuzumab (ALZ) is a humanized monoclonal antibody approved for the treatment of patients with highly active relapsing-remitting multiple sclerosis (RRMS) administered in two annual courses. The objective of this study was to describe the effectiveness and safety data of ALZ and to report the health resource utilization in patients receiving this treatment.
Methods: In this retrospective, non-interventional study, information was retrieved from patients' medical charts at one center in Spain.
Background And Objectives: The most common adverse events (AEs) after alemtuzumab (ALZ) include adverse infusion reactions, infections, and autoimmune disorders. Skin AEs are common during infusion, but there are few reported cases of long-term skin autoimmune disease.
Methods: A retrospective case series of patients developing long-term autoimmune skin disorders after ALZ administration in a tertiary care hospital.
Quality of life (QOL) plays an important role in independent living in Parkinson's disease (PD) patients, being crucial to know what factors impact QoL throughout the course of the disease. Here we identified predictors of QoL impairment in PD patients from a Spanish cohort. PD patients recruited from 35 centers of Spain from the COPPADIS cohort from January 2016, to November 2017, were followed up during 2 years.
View Article and Find Full Text PDFEpidemiology of balance disorders in primary care.
Acta Otorrinolaringol Esp (Engl Ed)
October 2021
Article Synopsis
- * A total of 7,896 patients visiting primary care for vertigo, imbalance, or dizziness were analyzed over one year, revealing an annual incidence of BD of 2.2%, with the majority diagnosed and treated within primary care settings.
- * Key findings showed that positional vertigo was the most common diagnosis, followed by vestibular migraines, central nervous system ischemia, and medication side effects, indicating a need for better training in these areas for primary care physicians.